Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock Position Lifted by Silver Oak Securities Incorporated

Silver Oak Securities Incorporated grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 12.8% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,784 shares of the medical equipment provider’s stock after acquiring an additional 203 shares during the quarter. Silver Oak Securities Incorporated’s holdings in Intuitive Surgical were worth $940,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in ISRG. M.E. Allison & CO. Inc. bought a new position in shares of Intuitive Surgical in the 4th quarter worth about $449,000. Seilern Investment Management Ltd acquired a new stake in Intuitive Surgical during the fourth quarter worth about $82,517,000. Exome Asset Management LLC lifted its holdings in Intuitive Surgical by 16.8% in the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after acquiring an additional 1,069 shares during the last quarter. China Universal Asset Management Co. Ltd. boosted its stake in Intuitive Surgical by 5.6% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock valued at $5,138,000 after acquiring an additional 525 shares during the period. Finally, Consolidated Planning Corp grew its holdings in shares of Intuitive Surgical by 17.4% during the third quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock valued at $3,979,000 after purchasing an additional 1,198 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Intuitive Surgical

In related news, CFO Jamie Samath sold 94 shares of the stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the completion of the transaction, the chief financial officer now owns 2,630 shares in the company, valued at $1,502,019.30. This trade represents a 3.45 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at $2,967,734. This represents a 6.39 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 5,940 shares of company stock valued at $3,333,485 over the last ninety days. Insiders own 0.80% of the company’s stock.

Intuitive Surgical Trading Down 0.4 %

NASDAQ:ISRG opened at $588.50 on Friday. The company has a 50-day moving average of $553.03 and a 200-day moving average of $512.59. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00. The firm has a market cap of $209.61 billion, a price-to-earnings ratio of 91.81, a price-to-earnings-growth ratio of 5.51 and a beta of 1.39.

Wall Street Analyst Weigh In

ISRG has been the topic of several recent research reports. Citigroup raised their price target on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a report on Friday, January 24th. Mizuho boosted their price target on shares of Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their target price for the company from $522.00 to $650.00 in a research note on Monday, December 2nd. Finally, Truist Financial raised their price target on shares of Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a research note on Friday, January 24th. One analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.